• Disease groups

• viral hepatitis

• Chronic liver disease

• Liver cirrhosis

• Liver cancer (HCC)

• Biliary tract disease

• Pancreatic disease

• Metabolic liver disease

• Hospital actions: Launched Taiwan’s first HCV reflex testing; set electronic alerts and automatic referrals for high‑risk patients; implemented mobile and inpatient screening; received national awards.

• Outreach actions: Large‑scale screening and onsite treatment in 22 hemodialysis units; two‑stage, door‑to‑door screening with a permanent outreach clinic in a 5,000‑resident township; early microelimination in a mountain district; expanded services to rural, indigenous, prison, psychiatric, and island populations using point‑of‑care fingertip testing.

HCV reflex 2.HCV point of care testing 3. outreach clinic 4. web of HCV care cascade roadmap

In hospital 17750 patients. Outreach patients including hyperendemic region, rural areas, indgenous villiages, uremic patients on maintained hemodialysis, marginized population:15000 patients

community effectiveness of HCV microelimination from HCV diagnosis to HCV cure: indgenous villiages 98.6%.hyperendemic region76%.uremic patients on maintained hemodialysis 92.3%. SVR12>95% in hyprendemic area and marginized populations

First repor of sfety and DDI of DAAs in the use of hemodialysis patients and serious mental disease patients

> 90% ssatisfaction of patients and co-care givers

Guideline of 2022 KIDGO. 2. review article to represent Taiwan HCV microelmination in the the hyperendemic area and hemodialysis in JFMA 2025

The first longitudinal report to prove the concept of "treatment as prevention" in the uremic patients at the public health level